FDA Gives Green Light on Another Round of Boosters

FDA Gives Green Light on Another Round of Boosters

(DailyVantage.com) – Ever since the COVID-19 vaccines rolled out in December 2020, the CDC has been wavering with its guidance. At first, people expected they would need two doses of either the Moderna or Pfizer vaccines or a single dose of Johnson & Johnson to be fully vaccinated. Then, several months later, J&J disappeared off the market, but the other two pharmaceutical companies came out with a third shot — or booster. Now, the CDC is recommending some individuals receive a fourth shot, and the FDA just greenlighted it.

On Tuesday, March 29, the FDA approved a fourth shot for adults 50 and older, saying these individuals are at a higher risk. Both Pfizer and Moderna sought approval for this shot, with Pfizer focusing on adults 65 and up, while Moderna wanted all adults covered.

In an FDA news release, the agency has called on the higher-risk groups to receive the fourth shot if it’s been at least four months since their booster, saying “current evidence suggests some waning of protection.” The CDC has updated its website to reflect this recommendation.

Critics are already questioning the need for yet another shot, especially with the high number of Omicron breakthrough infections.

What do you think about the FDA’s recommendation? Reply to your email and let us know. We’d love to hear from you!

Copyright 2022, DailyVantage.com